Fitzgerald LW[au] - Search Results

Year	Number of Results
1988	1
1989	2
1990	3
1991	2
1992	1
1993	3
1994	1
1995	4
1996	2
1997	1
1998	2
1999	5
2000	3
2002	1
2003	5
2007	1
2008	1
2009	1
2010	1
2011	1
2013	1
2020	1
2022	0

1

Cancer-Associated Muscle Wasting-Candidate Mechanisms and Molecular Pathways.

Armstrong VS, Fitzgerald LW, Bathe OF. Armstrong VS, et al. Among authors: fitzgerald lw. Int J Mol Sci. 2020 Dec 4;21(23):9268. doi: 10.3390/ijms21239268. Int J Mol Sci. 2020. PMID: 33291708 Free PMC article. Review.

2

Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action.

Lanz TA, Guilmette E, Gosink MM, Fischer JE, Fitzgerald LW, Stephenson DT, Pletcher MT. Lanz TA, et al. Among authors: fitzgerald lw. Mol Autism. 2013 Nov 15;4(1):45. doi: 10.1186/2040-2392-4-45. Mol Autism. 2013. PMID: 24238429 Free PMC article.

3

Molecular and cellular adaptations in signal transduction pathways following ethanol exposure.

Fitzgerald LW, Nestler EJ. Fitzgerald LW, et al. Clin Neurosci. 1995;3(3):165-73. Clin Neurosci. 1995. PMID: 8612061 Review.

4

Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.

Knauer CS, Campbell JE, Chio CL, Fitzgerald LW. Knauer CS, et al. Among authors: fitzgerald lw. Naunyn Schmiedebergs Arch Pharmacol. 2009 May;379(5):461-71. doi: 10.1007/s00210-008-0378-4. Epub 2008 Dec 5. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 19057895

5

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist.

He L, Gilligan PJ, Zaczek R, Fitzgerald LW, McElroy J, Shen HS, Saye JA, Kalin NH, Shelton S, Christ D, Trainor G, Hartig P. He L, et al. Among authors: fitzgerald lw. J Med Chem. 2000 Feb 10;43(3):449-56. doi: 10.1021/jm9904351. J Med Chem. 2000. PMID: 10669572

6

Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics.

Lee T, Robichaud AJ, Boyle KE, Lu Y, Robertson DW, Miller KJ, Fitzgerald LW, McElroy JF, Largent BL. Lee T, et al. Among authors: fitzgerald lw. Bioorg Med Chem Lett. 2003 Feb 24;13(4):767-70. doi: 10.1016/s0960-894x(02)01028-4. Bioorg Med Chem Lett. 2003. PMID: 12639577

7

Messenger RNA editing of the human serotonin 5-HT2C receptor.

Fitzgerald LW, Iyer G, Conklin DS, Krause CM, Marshall A, Patterson JP, Tran DP, Jonak GJ, Hartig PR. Fitzgerald LW, et al. Neuropsychopharmacology. 1999 Aug;21(2 Suppl):82S-90S. doi: 10.1016/S0893-133X(99)00004-4. Neuropsychopharmacology. 1999. PMID: 10432493

8

Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures.

Fitzgerald LW, Kaplinsky L, Kimelberg HK. Fitzgerald LW, et al. J Neurochem. 1990 Dec;55(6):2008-14. doi: 10.1111/j.1471-4159.1990.tb05789.x. J Neurochem. 1990. PMID: 1700071

9

Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress.

Ortiz J, Fitzgerald LW, Lane S, Terwilliger R, Nestler EJ. Ortiz J, et al. Among authors: fitzgerald lw. Neuropsychopharmacology. 1996 Jun;14(6):443-52. doi: 10.1016/0893-133X(95)00152-4. Neuropsychopharmacology. 1996. PMID: 8726755

10

The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist.

Gilligan PJ, Baldauf C, Cocuzza A, Chidester D, Zaczek R, Fitzgerald LW, McElroy J, Smith MA, Shen HS, Saye JA, Christ D, Trainor G, Robertson DW, Hartig P. Gilligan PJ, et al. Among authors: fitzgerald lw. Bioorg Med Chem. 2000 Jan;8(1):181-9. doi: 10.1016/s0968-0896(99)00271-0. Bioorg Med Chem. 2000. PMID: 10968277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results